E. Nobileorazio et al., SERUM IGG ANTIBODIES TO A 35-KDA P0-RELATED GLYCOPROTEIN IN MOTOR-NEURON DISEASE, Journal of neuroimmunology, 53(2), 1994, pp. 143-151
Using an immunoblot technique we found a significantly higher frequenc
e of serum IgG antibodies to a 35-kDa peripheral nerve myelin glycopro
tein in patients with motor neuron disease (MND) (39% of 70) than in p
atients with neuropathy (13% of 61), other neurological diseases (9% o
f 32) and normal subjects (5% of 20) (P < 0.005 in all cases), but not
with multiple sclerosis (MS) (20% of 30) or non-neural immune disease
s (25% of 32). Most positive patients had antibody titers of 1:200 or
1:2000 while higher titers were only found in seven patients with MND,
one with chronic inflammatory demyelinating neuropathy, two with MS,
two with non-neural immune diseases and one with stroke. The reacting
protein had a higher molecular mass than P0 and was only faintly bound
by an anti-P0 antiserum, but had the same N-terminal amino acid seque
nce of P0. The difference in molecular mass between P0 and the 35-kDa
protein and the IgG reactivity of one patient's IgG with the 35-kDa pr
otein persisted after its deglycosylation and dephosphorylation. Altho
ugh there is no evidence that these antibodies are pathogenic, their f
requent occurrence in MND and other immune-mediated conditions support
s the hypothesis of an activation of the immune system in MND.